[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:vestibular-schwannoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":68,"states":69},"Vestibular Schwannoma",9,7,[8,16,22,29,35,41,47,54,61],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06517888","Anti-VEGF Gene Therapy Trial for Vestibular Schwannoma",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:29.353236Z","2026-05-05T02:43:28.547818Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05622344","StableEyes With Active Neurofeedback",[],"2026-08-26T02:15:50.539717Z","2026-05-05T02:43:27.662176Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT04374305","Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)",[26],"Phase 2","2026-08-26T02:18:34.622081Z","2026-05-13T02:55:06.248563Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT03510208","Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery",[12],"2026-08-26T02:15:27.567165Z","2026-04-29T02:57:57.082045Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT00598351","Natural History Study of Patients With Neurofibromatosis Type 2",[],"2026-08-26T02:18:07.037408Z","2026-05-13T02:55:06.039407Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT05702749","Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas",[],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:29.732796Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07493447","Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures",[51],"Early Phase 1","2026-08-26T02:18:38.077159Z","2026-07-05T03:45:20.252798Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07503613","Long Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy",[],"ENROLLING_BY_INVITATION","2026-08-26T02:16:02.918558Z","2026-06-16T05:54:07.885980Z",{"nct_id":62,"title":63,"phases":64,"status":65,"updated_at":66,"content_modified":67},"NCT03795675","CI Following VS Removal or Labyrinthectomy",[],"ACTIVE_NOT_RECRUITING","2026-08-03T03:18:16.987470Z","2026-05-05T02:43:29.068657Z",[],[70],{"state":71,"count":72,"slug":73},"Maryland",4,"maryland"]